Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability

dc.contributor.author	Tas, B.
dc.contributor.author	Durmus, I.F.
dc.contributor.author	Okumus, A.
dc.contributor.author	Uzel, O.E.
dc.contributor.author	Gokce, M.
dc.contributor.author	Goksoy, H.S.
dc.contributor.author	Ozsahin, E.M.
dc.date.accessioned	2021-12-21T08:41:01Z
dc.date.available	2021-12-21T08:41:01Z
dc.date.issued	2018
dc.identifier.issn	1678140
dc.identifier.uri	https://doi.org/10.1016/j.radonc.2018.08.005
dc.identifier.uri	http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1290
dc.description.abstract	Purpose: To report the feasibility, accuracy, and reliability of volumetric modulated arc therapy (VMAT)-based total-body irradiation (TBI) treatment in patients with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL). Materials and method
dc.language.iso	English
dc.publisher	Elsevier Ireland Ltd
dc.title	Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability
dc.type	Article
dc.relation.journal	Radiotherapy and Oncology
dc.identifier.issue	3
dc.identifier.startpage	527
dc.identifier.endpage	533
dc.identifier.volume	129
dc.identifier.doi	10.1016/j.radonc.2018.08.005
dc.relation.issue	3
dc.relation.volume	129